Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments-Reference-Cited by-同舟云学术

Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

Published:2015-12 Issue:6 Volume:15 Page:512-518
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Yu Jeong Il,Park Won,Choi Doo Ho,Huh Seung Jae,Nam Seok Jin,Kim Seok Won,Lee Jeong Eon,Kil Won Ho,Im Young-Hyuck,Ahn Jin Seok,Park Yeon Hee,Cho Eun Yun

Funder

Samsung Medical Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Korean Breast Cancer White Paper 2013;Korean Breast Cancer Society;Korean Breast Cancer Soc,2014

2. Breast cancer statistics, 2011;DeSantis;CA Cancer J Clin,2011

3. Global cancer statistics;Jemal;CA Cancer J Clin,2011

4. Cancer treatment and survivorship statistics, 2014;DeSantis;CA Cancer J Clin,2014

5. Cancer survivors–United States, 2007;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009;Clinical and Translational Oncology;2023-01-07

2. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement;International Journal of Radiation Oncology*Biology*Physics;2022-07

3. Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System;Frontiers in Cell and Developmental Biology;2022-04-04

4. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3;Clinical Breast Cancer;2020-12

Clinical Outcomes of N3 Breast Cancer: A Real-World Study of a Single Institution and the US Surveillance, Epidemiology, and End Results (SEER) Database

;Cancer Management and Research;2020-07